In a new job - May 14, 2026
Finnish Bioindustries Association elects new Board of Directors
Finnish Bioindustries Association has elected a new Board of Directors:
Global report - May 12, 2026
Bristol Myers Squibb and Hengrui Pharma announce strategic agreements
The companies have entered into global strategic collaboration and license agreements to advance a portfolio of 13 early stage programs in oncology, hematology and immunology.
Clinical Trials - May 12, 2026
AnaCardio announces Phase 1b/2a results
AnaCardio has announced detailed results from its Phase 1b/2a GOAL-HF1 study evaluating AC01 in patients with heart failure with reduced ejection fraction (HFrEF).
Biotech Business - May 11, 2026
FDA extends sBLA review of Leqembi Iqlik
BioArctic’s partner Eisai has announced that the FDA has extended the review period by three months for the supplemental Biologics License Application (sBLA) for a once weekly lecanemab irmb subcutaneous injection, also known as Leqembi Iqlik, as a starting dose for the treatment of early Alzheimer’s disease.
Collaboration - May 11, 2026
Cereno Scientific enters collaboration with PHA Europe & Global
Cereno Scientific has announced a collaboration with the patient organization PHA Europe & Global.
Biotech Business - May 11, 2026
Oncopeptides to submit type II variation to expand Pepaxti label
Oncopeptides has announced its intention to submit a Type II variation application to the European Medicines Agency (EMA).
